| 5061 |
Evaluation of the Safety and Bioactivity of Two Doses of Intravitreal Injection of Sirolimus in Patients with Non-infectious Uveitis |
Department of Ophthalmology |
2016 |
| 5062 |
Evaluation of the Safety and Bioactivity of Two Doses of Intravitreal Injection of Sirolimus in Patients with Non-infectious Uveitis |
Department of Ophthalmology |
2016 |
| 5063 |
Evaluation of the Safety and Bioactivity of Two Doses of Intravitreal Injection of Sirolimus in Patients with Non-infectious Uveitis |
Department of Ophthalmology |
2016 |
| 5064 |
Evaluation of TNF– α, Nitric Oxide, Lipid Profile, Urea and Creatinine Serum Levels for the Prediction of Preeclampsia |
Department of Clinical Pathology |
2016 |
| 5065 |
Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes |
Department of Obstetrics and Gynecology |
2016 |
| 5066 |
Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes |
Department of Obstetrics and Gynecology |
2016 |
| 5067 |
Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes |
Department of Obstetrics and Gynecology |
2016 |
| 5068 |
Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes.
|
Department of Obstetrics and Gynecology |
2016 |
| 5069 |
Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes.
|
Department of Obstetrics and Gynecology |
2016 |
| 5070 |
Expected probability of congenital heart disease and clinical utility of fetal echocardiography in pregnancies with pre-gestational diabetes.
|
Department of Obstetrics and Gynecology |
2016 |
Do you have any questions? 
